Bio-Techne TECH Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Based on trailing twelve months.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's free cash flow margin?
- Bio-Techne (TECH) reported free cash flow margin of 22.3% in Q1 2026.
- How has Bio-Techne's free cash flow margin changed year-over-year?
- Bio-Techne's free cash flow margin increased by 21.9% year-over-year, from 18.3% to 22.3%.
- What is the long-term trend for Bio-Techne's free cash flow margin?
- Over 4 years (2021 to 2025), Bio-Techne's free cash flow margin has grown at a -10.7% compound annual growth rate (CAGR), from 33.1% to 21%.
- What does free cash flow margin mean?
- How much real, spendable cash each sales dollar generates after reinvestment.
- How do you interpret free cash flow margin?
- A high and rising FCF margin is the hallmark of a cash-generative business. Persistent gaps between net margin and FCF margin warrant a look at working capital or capital intensity.
- How does free cash flow margin compare across companies?
- Strong cross-company quality signal; capital-light compounders post structurally higher FCF margins than asset-heavy peers.